4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-20-011752
EVP/Chief Scientific Officer sold 20,000 shares at $40.02 ($800,400)
- EVP/Chief Scientific Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Albright Charles · EVP/Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-07 | Exercise or conversion : show line 1 in the form | +20,000 | $16.51 | $330,200 | 44,907 | D |
| 2020-12-07 | Sale : show line 2 in the form | −20,000 | $40.02 | $800,400 | 24,907 | D |
| Open-market sales · 20,000 sh · avg $40.02 · $800,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-07 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −20,000 | 165,000 | D |
Loading xslF345X03/edgar.xml…